TNFSF4 and neoplasm: Under the synergistic or additive action of OV and OX40L, M2-like macrophages and protumor N2-like neutrophils showed reduced proportion and boosted anti-tumor immune responses, whereas pro-inflammatory N1-like neutrophils were remarkably increased after OV-mOX40L treatment.